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Sharon L. Sanders1*, John Rathbone1, Katy J. L. Bell1,2, Paul P. Glasziou1 and Jenny A. Doust1Abstract
Background: Diagnostic clinical prediction rules (CPRs) are worthwhile if they improve patient outcomes or
provide benefits such as reduced resource use, without harming patients. We conducted a systematic review to
assess the effects of diagnostic CPRs on patient and process of care outcomes.
Methods: We searched electronic databases and a trial registry and performed citation and reference checks, for
randomised trials comparing a diagnostic strategy with and without a CPR. Included studies were assessed for risk
of bias and similar studies meta-analysed.
Results: Twenty-seven studies evaluating diagnostic CPRs for 14 conditions were included. A clinical management
decision was the primary outcome in the majority of studies. Most studies were judged to be at high or uncertain
risk of bias on ≥3 of 6 domains. Details of study interventions and implementation were infrequently reported.
For suspected Group A Streptococcus throat infection, diagnostic CPRs reduced symptoms (1 study) and antibiotic
prescriptions (5 studies, RR 0.86, 95% CI 0.75 to 0.99). For suspected cardiac chest pain, diagnostic strategies
incorporating a CPR improved early discharge rates (1 study), decreased objective cardiac testing (1 study) and
decreased hospitalisations (1 study). For ankle injuries, Ottawa Ankle Rules reduced radiography when used with
clinical examination (1 study) but had no effect on length of stay as a triage test (1 study). For suspected acute
appendicitis, CPRs had no effect on rates of perforated appendix (1 study) or the number of non-therapeutic
operations (5 studies, RR 0.68, 95% CI 0.43 to 1.08). For suspected pneumonia, CPRs reduced antibiotic prescribing
without unfavourable outcomes (3 studies). For children with possible serious bacterial infection, diagnostic CPRs
did not improve process of care outcomes (3 studies).
Conclusion: There are few randomised trials of diagnostic CPRs, and patient outcomes are infrequently reported.
Diagnostic CPRs had a positive effect on process outcomes in some clinical conditions; however, many studies
were at unclear or high risk of bias and the results may be context specific. Future studies should seek to detail
how the CPR might alter the diagnostic pathway, report effects on both patient and process outcomes, and
improve reporting of the study interventions and implementation.
Trial registration: The protocol for this review was not registered with PROSPERO, the international prospective
register of systematic review protocols. The review was conceived and protocol prepared prior to the launch of
PROSPERO in February 2011.
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Diagnostic clinical prediction rules (CPRs) are tools
intended to supplement clinicians’ diagnostic reasoning
and judgment [1] by providing an estimate of the prob-
ability of the presence of a particular disease in an indi-
vidual and/or by suggesting a course of clinical action
based on the underlying probability estimate.
The decision to introduce a diagnostic CPR into prac-
tice should ideally be based on evidence that implemen-
tation leads to either (1) improved patient outcomes or
(2) other benefits such as reduced resource use, relative
to the current alternative pathway, without adversely
affecting patients. The vast majority of studies of diag-
nostic CPRs in the literature, however, have focused on
establishing the accuracy of the CPR relative to a refer-
ence standard test in derivation and validation studies,
with no comparison to the existing diagnostic pathway.
Often this information is used to decide on the clinical
usefulness of the CPR. However, diagnostic accuracy
does not necessarily translate into patient benefits [2],
nor is it a necessary prerequisite for improved pa-
tient health as a CPR may alter patient outcomes
through other non-decisional routes including by
changing the timing of decisions and actions relative
to the existing pathway or through direct effects of
the CPR itself [3, 4]. Therefore, impact studies of
diagnostic CPRs are necessary. These studies compare test-
ing strategies with and without a diagnostic CPR reporting
relevant patient and/or process of care outcomes [5].
Whether implementation of current, validated diag-
nostic CPRs leads to more benefit than harm is
unclear. The effects of CPRs as part of a broader
group of clinical decision support tools (computerised
and non-computerised tools for improving clinical
decision-making including, among other things, pre-
diction rules, guideline-based recommendations, alerts
or reminders, condition-specific order sets and con-
textually relevant reference information) have been
extensively reviewed [6–10]. However, the effect of
prediction rules specifically is difficult to discern from
these reviews as the effects have not been analysed
according to the type of clinical decision support sys-
tem implemented. A recent systematic review provides
some insight into the impact of both prognostic and
diagnostic CPRs relevant to primary care [11]. This re-
view included randomised and non-randomised stud-
ies evaluating CPRs as a stand-alone intervention
identified from a register of CPRs considered relevant
to primary care [12]. This review found that relatively
few CPRs for primary care had gone through impact
analysis and that a patient outcome was rarely the pri-
mary outcome. To our knowledge, there has been no
review of the effect of diagnostic CPRs alone that have
been developed for a range of conditions commonlyencountered in clinical medicine and used as a stand-
alone tool or as part of a care pathway, and including
only studies of randomised design. Such a review may
inform the selection and implementation of diagnostic
CPRs in a wide range of practice settings and guide fu-
ture diagnostic CPR research.
To determine the effect of diagnostic CPRs on patient
and process outcomes, we reviewed studies randomly al-
locating clinicians or patients to care provided with a
diagnostic CPR or to care without a diagnostic CPR.
Methods
We conducted the systematic review according to the
PRISMA statement reporting guidelines (see Additional
file 1).
Data sources and searches
We searched MEDLINE and The Cochrane Central
Register of Controlled Trials (CENTRAL) to September
2016 using MeSH and text word terms for the interven-
tion and a study design filter (Additional file 2). We
checked systematic reviews of diagnostic clinical pre-
diction rules and clinical decision support systems
identified through searching PubMed Clinical Queries.
Reference lists of studies obtained in full text were
checked, and studies included in the review were for-
ward searched using the Science Citation Index
Expanded in Web of Science. The International Clinical
Trials Registry Platform (ICTRP) was searched
(September 2016) to identify trials planned, in progress
or recently completed.
Study inclusion and exclusion criteria
We included randomised controlled trials allocating
clusters of individuals, or individual clinicians or pa-
tients, to a group ‘exposed’ to a diagnostic strategy com-
prised of or incorporating a previously derived
diagnostic CPR (experimental) or to care provided with-
out a CPR (control) that measured the impact of the
CPR on patient outcomes and/or health care processes.
Eligible experimental interventions comprised the
provision of a diagnostic CPR or the output of it or a
diagnostic strategy incorporating a diagnostic CPR (for
example a strategy including a CPR and another labora-
tory or imaging test) to a clinician. A diagnostic CPR
was defined as a combination of variables obtained from
history, examination or diagnostic testing, developed
using a statistical method and which provides a prob-
ability of the presence of disease for an individual and/or
suggested a diagnostic or therapeutic course of action
based on the underlying probability, such as further test-
ing or management or both. We excluded studies evalu-
ating tools incorporating a CPR designed for use by the
patient or as part of joint decision-making by the
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alternative diagnostic test or testing pathway that did
not incorporate the diagnostic CPR. Studies reporting
diagnostic accuracy as the primary outcome were in-
cluded if a current and adequate reference standard was
used.
Titles and abstracts were screened by one reviewer
and obviously irrelevant articles excluded. A second re-
viewer independently screened 15% of the titles and ab-
stracts. The second reviewer did not identify any titles
or abstracts as potential inclusions that were ultimately
included in the review, but considered not relevant by
the first reviewer. Full-text articles of potentially relevant
studies were obtained and independently assessed by
two reviewers against the review inclusion criteria. Dis-
crepancies were resolved through discussion with a third
reviewer.
Data extraction
Two reviewers independently extracted data from the in-
cluded studies. We extracted information on the experi-
mental arm including:
a) The prediction rule or diagnostic strategy tested
and its role in the existing diagnostic pathway
(replacement, triage or add-on) [13]
b) Whether the strategy was assistive (e.g. provided
a probability estimate or risk classification) or
directive (e.g. suggested or recommended a
course of action)
c) Whether the use of the prediction tool was
discretionary (e.g. the study methods stated the
clinician could choose to use or not use the
prediction tool) or expected (e.g. the study methods
implied or stated that the prediction tools were to
be used by clinicians)
d) Whether application of the output of the CPR
(when the CPR output was a suggested course of
action) was discretionary (e.g. the study report
stated a clinician could decide whether to follow the
rule recommendation or override it) or mandatory
(e.g. the recommendation of the CPR was followed
in all patients)
For the control arm of the studies, we extracted the
description of care as reported by the study authors. For
studies describing the control arm only as ‘usual prac-
tice’ or similar, we noted whether the study design may
have led to some modification of usual practice (for ex-
ample where clinicians in the control group may have
received training or information on the CPRs under
evaluation).
We also assessed whether elements of the study inter-
ventions necessary for interpretation of study findingsand replication in clinical practice were reported. We
determined the minimum items required for reporting
of the interventions through discussion and consider-
ation of internationally accepted standards for reporting
of clinical trials [14, 15]. This included a description of
the diagnostic strategies tested (beyond stating the name
of the test), a description of the criteria used for estab-
lishing a diagnosis or treatment decision and, for studies
reporting primary outcomes affected by administration
of selected treatments (e.g. patient symptoms), a descrip-
tion of the administered treatment. For the experimental
arm, reporting of aspects of implementation (e.g. train-
ing in or exposure to the diagnostic strategy) was also
assessed. The items were judged as ‘reported’ if any rele-
vant information was described.
Risk of bias assessment
Two reviewers independently assessed risk of bias ac-
cording to the Cochrane Risk of Bias Tool [16]. This
domain-based evaluation involved independent assess-
ment of risk of bias due to selection, performance, de-
tection, attrition, reporting and others. We considered
the following features to judge the risk of bias for each
domain: random sequence generation, allocation con-
cealment (selection bias), blinding of participants (per-
formance bias), blinding of outcome assessors (detection
bias), incomplete outcome data (attrition bias) and se-
lective reporting (reporting bias). We assessed the
methods as low risk, high risk or unclear risk for each
domain. We resolved any disagreement through discus-
sion with a third reviewer. Assessments of risk of bias
arising from allocation concealment were based on the
methods used to assign clusters of individuals (hospitals
or practices), individual clinicians or individual patients
to experimental or control groups. Judgments on the
likelihood of detection bias were based on details about
how outcomes were determined, ascertained or verified
and the subjectivity of the primary outcome of the study.
For trials that randomised centres, and trials that rando-
mised individual clinicians who then recruited partici-
pants to the study, we also assessed risk of bias arising
from the recruitment of patients to the study by clini-
cians aware of their allocation (recruitment bias). For
these studies, we also assessed whether the analysis had
been adjusted for clustering and whether there was base-
line comparability of clusters or statistical adjustment
where there was imbalance. The potential for contamin-
ation was also recorded. Contamination may occur, for
instance, when patients are randomised to either the
intervention or control group with the clinician switch-
ing between use and no use of the prediction rule, or
when clinicians within the same centre randomised to
different study groups discuss their experiences. Assess-
ments of risk of bias arising from incomplete outcome
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comes and the reasons for the missing outcomes with
studies considered to be at low risk of attrition bias if
there was no missing outcome data, or if the missing
outcome data was balanced between study arms and the
reasons given for the missing data did not have different
implications for each study arm. Selective reporting
within each study was assessed by comparing outcomes
listed in the study protocol and the outcomes presented
in the published report. When a study protocol was not
available, the outcomes described in the method section
of the published report were compared to the outcomes
presented in the results section.
Data synthesis and presentation and exploration of
heterogeneity
Given differences in the objectives of the included trials
and CPRs applicable to each condition, we expected het-
erogeneity in the outcomes reported between and within
clinical conditions. To facilitate interpretation, we
grouped the included studies by clinical condition. We
extracted data on the following types of outcomes: (a)
patient outcomes, such as mortality, clinical events,
health-related quality of life, patient symptoms or ad-
verse events; (b) health care service outcomes, such as
length of stay or time to operation; (c) effect on clinical
decisions (test ordering, treatment or referral decisions);
(d) appropriateness of clinical decisions (e.g. discharge
from care and no serious adverse events); (e) diagnostic
accuracy (agreement with a reference standard test) and
(f ) adherence and implementation outcomes (e.g. use of
the tool or compliance with the output of a directive
CPR).
For dichotomous outcomes, we presented the adjusted
estimates of effect reported in the paper and calculated
risk ratios and 95% confidence intervals when this was
possible and not presented. For instances where the
intervention is intended to prevent an undesirable out-
come (e.g. symptoms or antibiotic prescribing), an OR,
HR or RR of <1 indicates the intervention is better than
the control. Where the intervention is intended to pro-
mote a positive event (e.g. safe discharge), an OR, RR or
HR >1 confirms treatment efficacy. Continuous outcome
measures are presented as reported in the paper. For
each study, we identified the primary outcome. The pri-
mary outcome was considered to be either the outcome
stated by the study as being the primary outcome or the
outcome for which a power calculation was conducted.
In the absence of these, the primary outcome was con-
sidered to be the outcome mentioned in the study ob-
jective or reported first in the results section. Statistical
analysis was carried out using the Cochrane Collabora-
tion’s Review Manager (Version 5.3) software. Based on
difficulties arising from meta-analysing a small numberof studies, we combined results when five or more stud-
ies for a clinical condition assessed the same outcome,
in the same manner, regardless of the specific prediction
tool or diagnostic strategy, to obtain a pooled estimate
of effect using the general inverse variance method [17].
We chose the risk ratio, a relative measure of effect, as
the summary statistic for its ease of interpretation [16].
We considered clinical heterogeneity sufficient to expect
that the underlying treatment effects differed between
trials. Consequently, we used a random effects model to
produce an overall summary of the average treatment ef-
fect across the included studies. For studies including
two experimental arms (e.g. CPR and CPR plus rapid
antigen detection test (RADT)) [18, 19], we included
data only from the CPR-alone arm in the meta-analysis.
For the one study including two control arms (e.g. clin-
ical judgment with no diagnostic aid or with a standar-
dised data collection form) [20], we included data only
from the clinical judgment with no diagnostic aid arm.
To pool individual and cluster randomised trials in the
same model, adjustment for clustering was conducted.
Adjustment involved reducing the size of the cluster tri-
als to the effective sample size by dividing the sample
size by the design effect, where the design effect is equal
to 1 + (m − 1) × intracluster correlation coefficient (ICC)
and m is the average cluster size [16]. To calculate the
design effect for studies of sore throat, we used the
intracluster correlation coefficient reported in a dupli-
cate publication of one of the other sore throat studies
[21]. For appendicitis studies, we used the median ICC
reported for implementation research studies report-
ing process variables (ICC 0.063) and undertook sensi-
tivity analysis using the extremes of the interquartile
range [22].
Results
Study selection
Of 12,511 titles and abstracts screened, 175 were ob-
tained in full text and 27 studies were included in the re-
view (Fig. 1) [18–20, 23–46]. The 148 full-text excluded
studies are presented in Additional file 3 with reasons
for their exclusion.
Study characteristics
Characteristics of the 27 included studies, grouped by
the clinical condition for which the CPR was developed,
are presented in Table 1.
Eleven of the 27 included studies were considered to
have evaluated a diagnostic CPR or strategy designed to
replace the existing approach [18, 24, 28, 33, 34, 37, 40,
41, 44–46], 12 assessed the impact of adding a CPR to
the usual diagnostic pathway in order to evaluate the
benefit of extra information to diagnostic decision-
making [19, 23, 25, 27, 30–32, 36, 38, 39, 42, 43], while
Fig. 1 Study flow diagram
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age studies, the CPR was used before the existing test to
determine which patients undergo the existing test [26,
29, 35]. One study with three intervention arms evalu-
ated a CPR as both a replacement and add-on test [20].
In 19 of 27 studies, the CPR was introduced as a stand-
alone tool [20, 23, 24, 26–34, 36, 38, 39, 41, 43–45]. The
diagnostic CPRs and strategies tested were directive in 25
of the 27 studies, making a recommendation regarding
treatment or disposition in 10 studies [19, 24, 27, 30, 31,
37, 40, 41, 44, 45], further diagnostic testing in 8 studies
[23, 26, 29, 35, 36, 38, 39, 43] and both further testing and
treatment in 7 studies [18, 25, 28, 32–34, 46].
In most studies (18/27), the control group intervention
was variably described as ‘clinicians’ assessment’ or
‘usual care’ [19, 23, 25–32, 36, 38, 39, 41–43, 45, 46].
This ranged from control groups in which clinicians
were explicitly asked not to change their usual practice,
and control groups where clinicians received informa-
tion on the CPRs being tested in the intervention arm,
to control groups where clinicians’ actions were ex-
pected to be based on local care guidelines. In the
remaining studies, the control group intervention was a
standard data collection form, a specific care pathway(e.g. a chest pain clinic protocol or delayed antibiotic
strategy) or a single diagnostic test.
Patient outcomes were considered the primary out-
come in 3 [18, 28, 35] of the 27 studies, and process of
care outcomes (e.g. length of stay) were the primary
study outcome in 5 [25–27, 36, 37]. A clinical decision
was the primary outcome in 12 studies [19, 21, 23, 29,
32, 38, 39, 41, 43–45, 47], and the appropriateness of the
decision was the primary outcome in 3 [34, 40, 42]. Ac-
curacy of a diagnosis or decision was the primary out-
come in 4 studies [20, 24, 30, 31]. The types of primary
and secondary outcomes reported in the included stud-
ies are shown in Additional file 4.
Risk of bias
The majority of studies included in the review (20/27
(74%)) were judged to be at unclear or high risk of bias
on 3 or more domains including performance bias. Con-
cealment of allocation, one of the key domains in the as-
sessment of bias, was reported in insufficient detail to
enable accurate judgment or was considered inadequate
in over half of the included studies (19/27 (70%)). Due
to the nature of the intervention, in most studies in-
cluded in this review, clinicians would have been aware
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of performance bias to be high in the majority (24/27
(89%)) of the included trials and unclear in 1 study. In
this study, the interventions were very similar, and the
study stated that clinicians were not aware of the alter-
nate interventions. Figure 2 provides a summary of risk
of bias judgments for each domain of bias presented as
percentages (a) across all included studies and (b) for
studies using a cluster randomised design. Details of the
risk of bias assessment for each domain of bias for each
study are presented in Additional file 5.
Assessment of the reporting of interventions
We found reporting of interventions in these studies
incomplete, with details of the components necessary
to replicate the intervention often missing (Additional
file 6). When present, they were usually only partly de-
scribed (for example a diagnostic strategy comprising a
CPR and laboratory test described the technique used
to perform the laboratory test but did not describe the
CPR) or were described with very low level of detail.
Only 1 of 25 included studies were judged to have de-
scribed the diagnostic strategy and criteria for arriving
at a diagnosis or decision in both the experimental and
control groups [37] and 6 studies to have reported both
whether training or exposure to the CPR was provided
and the means by which the CPR was implemented into
the workflow [23, 26, 32, 36, 42, 43]. Control interven-
tions that were variably described as ‘usual’ care were
less frequently described than control interventions
comprising more technological procedures (e.g. con-
trast radiography).
Effects of diagnostic strategies incorporating diagnostic
clinical prediction rules
The estimated effects of exposure to a diagnostic strategy
incorporating a diagnostic CPR are presented according
to the clinical condition the CPR was developed to detect.a
b
Fig. 2 Review authors’ judgments about each risk of bias domain prese
cluster-randomised studies. Legend: low risk of bias,Studies of diagnostic CPRs for suspected Group A
Streptococcus throat infection
Tabulated results are presented in Additional file 7.
Five studies evaluated three different CPRs (Walsh,
Centor and FeverPAIN score) and a modified version of
one (Modified Centor Score) [18, 19, 32–34]. All CPRs
evaluated were directive (i.e. provided management rec-
ommendations), and in all five studies, application of the
output of the CPR or diagnostic strategy was discretion-
ary (i.e. the clinician could follow or not follow the rec-
ommendations of the CPR). Four of the five studies were
judged to be at high or unclear risk of bias on 3 or more
of the 6 key domains.
Clinical outcomes
In one study reporting patient-reported symptoms (pri-
mary study outcome) and adverse effects [18], there
were greater improvements in symptom severity among
patients randomised to the FeverPAIN score compared
to the control arm with a strategy of delayed antibiotics
(mean difference adjusted for baseline symptom severity
and fever −0.33 on a score of 0–6, 95% CI −0.64 to
−0.02, p = 0.04). Symptom resolution was faster among
patients randomised to the FeverPAIN score (HR ad-
justed for baseline symptom severity and fever 1.30, 95%
CI 1.03 to 1.63; median duration 5 days (IQR 3–7) in
the control arm and 4 days (IQR 2–6) in the score-only
arm). There were no differences between the study
groups in the proportion returning to the clinic with
sore throat within a 1-month period or the occurrence
of suppurative complications (none occurred during the
study).
Clinical decisions
All five studies reported clinical decisions to prescribe
antibiotics [18, 19, 32–34]. In the three studies reporting
clinical decisions to prescribe as the primary study out-
come, CPRs were associated with a non-significantnted as percentages a across all included studies and b for
unclear risk of bias, high risk of bias 
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ies reported no difference in emergency department or
outpatient visits as a proxy for the appropriateness of
care [32]. Complications either did not occur or were
not reported in the other two studies [19, 33]. In pooled
analysis, CPRs reduced antibiotic prescriptions com-
pared to care provided without a CPR (pooled RR 0.86,
95% CI 0.75 to 0.99) (Fig. 3).
The results of studies reporting the effects of diagnos-
tic CPRs on other clinical decisions including test use
and the appropriateness of antibiotic prescribing are
shown in Additional file 7.
Studies of diagnostic CPRs for suspected acute
appendicitis
Tabulated results are presented in Additional file 7.
Five studies evaluated three different CPRs (Alvarado
score, Lintula score and the Leeds decision support
system) [20, 25, 27, 30, 31]. The Leeds decision support
system was assistive, providing only an estimate of the
probability of appendicitis without recommending a
course of action, and application of the management
recommendations of the Alvarado and Lintula scores
was discretionary. All five studies were judged to be at
high or unclear risk of bias arising from lack of blinding
of care providers and outcome assessors.
Clinical outcomes
Perforated appendix rates did not significantly differ be-
tween the experimental group and a control group pro-
viding care without a diagnostic aid (RR 0.47, 95% CI
0.19 to 1.15) and a control group where clinicians used a
standard data collection form (RR 0.81, 95% CI 0.31 to
2.16) [20, 48].
Process of care outcomes
The results of two studies providing data on the effect of
CPRs on duration of hospitalisation among patients with
suspected appendicitis are conflicting. One small study
of the Alvarado score reported significantly shorter dur-
ation of hospitalisation in the intervention group (me-
dian 37.00 vs 60.40 h, p = 0.03) ‘without significantFig. 3 Meta-analysis of Group A Streptococcus throat infection studies for thincrease’ in perforation (one perforation occurred in the
intervention group and two perforations in the control
group) [27], while the other study reported no difference
in mean duration of hospital stay between a diagnostic
protocol incorporating the Alvarado score and graded
compression ultrasound, and the control group (mean
53.4 vs 54.5 h, p = 0.84) [25].
The results of studies reporting the effects of diag-
nostic CPRs on other process of care outcomes includ-
ing admission rates and time to surgery are shown in
Additional file 7.
Clinical decisions/appropriateness of clinical decisions
In pooled analysis of five trials, diagnostic strategies in-
corporating CPRs reduced unnecessary appendectomy
compared to usual clinical assessment, but this was not
statistically significant (pooled RR 0.68, 95% CI 0.43 to
1.08) [20, 25, 27, 30, 31]. The direction of effect was
consistently in favour of the experimental arms of the
trials, though the risk ratios varied widely (Fig. 4). An
ICC obtained from an analysis of implementation re-
search studies reporting process outcomes (ICC 0.063)
was used to adjust for clustering in the one cluster ran-
domised trial included in this analysis. In sensitivity ana-
lysis, using the lower extreme of the ICC interquartile
range, in which more weight is given to the study in the
meta-analysis similar to that applied when unadjusted
data are used, the confidence intervals were narrower
and the effect significant (pooled RR 0.64, 95% CI 0.41
to 0.98).
Studies of diagnostic CPRs for suspected serious bacterial
infection in children with fever
Tabulated results are presented in Additional file 7.
Three studies evaluated three different directive CPRs
[36, 43, 44]. All three were considered at high risk of
bias arising from a lack of blinding of care providers and
at unclear risk of bias for allocation concealment. There
was a non-statistically significant increased length of stay
in the emergency department with diagnostic strategies
incorporating a CPR in the two studies reporting this
outcome (138 vs 123 median minutes, p = 0.16, and 117e outcome antibiotic prescriptions
Fig. 4 Meta-analysis of appendicitis studies for the outcome unnecessary appendectomies
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control groups of both studies, respectively) [36, 43]. A
CPR comprised of a panel of three laboratory tests (pro-
calcitonin, C-reactive protein and urinary dipstick) did
not reduce antibiotic prescribing compared to the judg-
ment of clinicians with access to the results and associ-
ated treatment recommendation of the white blood cell
count, band count and C-reactive protein tests (pre-
scriptions for 41 and 42% of the experimental and con-
trol groups, respectively, p = 0.88) [44]. A CPR also had
no effect on the use of diagnostic tests when serious
bacterial infection was and was not present as judged
by a reference standard (60 vs 57% of children without
pneumonia in the experimental and control groups, re-
spectively, received chest x-ray, p > 0.05, and 67 vs 53%
of children without urinary tract infection had urine
culture performed, p > 0.05) [43]. This CPR resulted in
a significant increase in the number of urine dipstick
tests, a significant reduction in the number of full blood
count tests and a non-significant decrease in the num-
ber of diagnostic tests overall compared to the control
group.
Studies of diagnostic CPRs for suspected acute coronary
syndromes
Tabulated results are presented in Additional file 7.
Three studies judged to be at low risk of bias evaluated
different diagnostic strategies incorporating different
CPRs and tests for individuals presenting with possible
cardiac chest pain [37, 40, 46]. In the first of these stud-
ies, a strategy incorporating a diagnostic CPR (TIMI
score), ECG and cardiac troponin testing significantly
increased the number of patients successfully dis-
charged within 6 h (discharge was considered success-
ful if it occurred within 6 h of emergency department
arrival and patient did not experience a major cardiac
adverse event within 30 days) (OR 1.92, 95% CI 1.18 to
3.13) [40], compared with a conventional chest pain
protocol. In the second study, a diagnostic strategy
comprising a CPR and NT-proBNP test decreased the
number of patients hospitalised (OR 0.6, 95% CI 0.4 to0.9) with no differences in death or myocardial infarc-
tion between study groups after 1-year follow-up [37].
In the final study, a strategy incorporating the HEART
score with serial troponin measures decreased objective
cardiac testing at 30 days (69 vs 57%, p = 0.04) com-
pared with usual care [46].
Studies of diagnostic CPRs for suspected (bacterial)
pneumonia
Tabulated results are presented in Additional file 7.
Three studies evaluated different CPRs in patients with
suspected pneumonia [32] and in patients (unvaccinated
and vaccinated against pneumococcus) with non-severe
community-acquired pneumonia (according to clinical
criteria) of unknown aetiology [41, 45]. All three studies
were judged to be at unclear or high risk of bias on 3 or
more domains of bias. Prescriptions for antibiotics were
significantly reduced with use of the CPR with no differ-
ence in unfavourable outcomes between interventions
[32, 41, 45].
Studies of diagnostic CPRs for suspected ankle or
mid-foot fracture
Tabulated results are presented in Additional file 7.
Two studies evaluated the impact of the Ottawa Ankle
Rules (OARs) [23, 26]. In one trial, the OARs were used
as a triage test [26]. This trial was judged to be at un-
clear or high risk of bias arising from inadequate ran-
domisation sequence generation, incomplete data and
selective reporting. In this trial, standard departmental
care was compared to a pathway in which the OARs
were applied at presentation: if positive, the patient was
x-rayed, and if negative, the patient underwent usual
clinical assessment. In the second trial [23], clinicians in
hospitals randomised to the intervention were encour-
aged to use the OARs as part of their clinical assess-
ment. This study was judged to be at high or unclear
risk of bias on 5 of the 6 domains of bias assessed and at
unclear risk from baseline differences between the ran-
domised groups. When used as a triage test, the OARs
did not decrease total length of stay in the emergency
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7.4), and there was no difference in patient satisfaction
ratings and radiography requests between the study
groups [26]. The OARs, when used and applied at the
discretion of the clinician as an add-on test, significantly
decreased radiography requests (76 vs 99%, p = 0.03).
Three fractures were later diagnosed among participants
who had not received an x-ray—all were randomised to
the experimental arm. However, there was no active
follow-up in this trial, and participants were only advised
to consult again if there was persistent pain or inability
to walk so it is possible other fractures may have been
missed. In this trial, 96 and 98% of patients in the ex-
perimental and control groups, respectively, were satis-
fied with the care received [23].Single studies of diagnostic CPRs for other conditions
Tabulated results are presented in Additional file 7.
Clinical outcomes
Two studies of CPRs for different clinical conditions
reported clinical outcomes as the primary outcome of
the study. In the first, a score-directed treatment al-
gorithm for patients with upper abdominal complaints
significantly decreased symptom severity (MD on a
scale of 0–10 2.5, 95% CI 1.49 to 3.51) [28]. The other
study was an equivalence trial of a triage strategy of
‘bedside tests’ incorporating a diagnostic CPR for
directing ventilation-perfusion scanning vs a strategy of
scanning all patients. In this study, there was no
significant difference in venous thrombotic events
among patients not taking anticoagulation agents
during follow-up (% difference in venous thrombo-
embolic event rate −0.6, 95% CI −4.1 to 2.9), but the
triage strategy excluded pulmonary embolism in 34% of
patients (who therefore avoided ventilation-perfusion
scanning) and reduced other diagnostic imaging tests
performed [35].Clinical decisions/appropriateness of clinical decisions
Radiography requests increased, but time in the emer-
gency department significantly decreased, in a study of
a CPR used as a triage test in children with extremity
trauma [29]. There was no difference in appropriate
referrals in adults with pigmented skin lesions with use
of a diagnostic protocol incorporating a CPR and the
MoleMate scanning technique [42]. A CPR for head
injured patients did not lead to a reduction in ED use
of CT imaging [39], but a CPR for patients with blunt
head and neck trauma and possible cervical spine frac-
ture significantly decreased imaging without missing
injuries [38].Discussion
The diagnostic CPRs evaluated in this review were found
to have beneficial effects on process outcomes in some
clinical conditions and in some cases had a positive
effect on patient health. Though improvement in patient
outcome, or increased efficiency of the diagnostic
process without worsening patient outcomes, is the ul-
timate measure of effectiveness for diagnostic CPRs, few
studies have primarily aimed to determine the effect of
diagnostic CPRs, or diagnostic strategies incorporating
CPRs, on patient outcomes. The majority of studies in-
cluded in this review investigated more intermediate
consequences of the use of the CPR, such as decisions
to test or treat. Study methods, intervention and imple-
mentation details necessary for interpretation and safe
application of the intervention were generally poorly re-
ported. This non-transparency hinders attempts to repli-
cate studies or their findings and erodes the value of the
research in this area [49, 50].
The conclusions drawn in this review are based on a
small number of studies, and, as a substantial number of
these studies were categorised as high or unclear risk of
bias on 3 or more domains of bias (one of which was
performance bias), caution is advised in interpretation of
their results. Further, the conclusions of many of the
studies included in this review are likely to be limited by
inadequate sample size [51]. Potential bias varied across
studies for different clinical conditions, and it was often
difficult to judge whether any bias would result in an
over- or underestimation of intervention effect. The
assessment of risk of bias relied upon the reporting of
trials, and there was insufficient detail to confidently
assess risk in many cases. Due to the nature of the inter-
ventions included in this review, which requires inter-
action with and interpretation by clinicians, blinding of
clinicians was not possible. As such, clinicians’ prior ex-
pectations of effectiveness of the intervention were
judged to have the potential to lead to bias either
through disparity in other care that is administered to
patients or by affecting clinicians’ decisions, which are
an outcome in many studies. The risk arising from non-
blinding of individuals assessing outcomes was judged
unclear for most studies. This was due to either inad-
equate reporting or absence of blinding of independent
data collectors or adjudicators.
The performance of the interventions evaluated in this
review is likely to be dependent on the context in which
the diagnostic strategy is implemented. For example, in
a study of the effect of a CPR for predicting streptococ-
cal infection conducted in general practice in the UK,
discretionary application of the CPR decreased the se-
verity of sore throat symptoms compared to a strategy
of delayed antibiotic prescribing [18]. It is not clear how
the prediction rule could affect resolution of sore throat,
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would respond to antibiotics more accurately or quickly.
In a setting where antibiotics are prescribed for sore
throat more frequently and possibly earlier, the relative
effect of the prediction rule on symptoms may be differ-
ent. As another example, a diagnostic strategy incorpor-
ating a CPR and BNP testing may lead to less hospital
admissions in a country where admissions for possible
cardiac chest pain are common [36], but may have less
effect in a situation where such admissions are
infrequent.
Within and across clinical conditions, there was het-
erogeneity in the degree to which CPRs and diagnostic
strategies incorporating CPRs were used and their out-
put applied. The protocols of the included studies took
one of two approaches to the use of the CPRs or diag-
nostic strategies: a pragmatic approach in which clini-
cians could decide whether or not to use the tool or an
approach in which clinicians in the study were expected
to use the CPR or were provided with the output from
it. Further, there were varying degrees to which the
clinician was required to follow the recommendation
provided by the directive rules or strategies. In some
studies, the subsequent treatment provided was dic-
tated entirely by the CPR. In others, the clinician was
‘encouraged’ to follow the recommendations, and in
others, clinicians could adopt or ignore the recommen-
dations at their discretion. These variations not only
may lead to differences in intervention effect but also
have implications for transferring the research findings
to clinical practice. Results from studies mandating use
of a CPR and carefully monitoring its correct applica-
tion may be different to results seen when the CPR is
introduced in a situation where clinicians are given
license to override its recommendations. It has been
suggested that impact studies should assess both actual
impact—impact when clinicians can use their discretion
in following the CPR recommendations, and potential
impact—measured by analysing the CPR-recommended
decision regardless of implementation by the clinician
[5]. This was done by two studies included in the
review [29, 44]. In one of these studies [44], strictly fol-
lowing the CPR recommendations would have resulted
in a treatment rate (antibiotic prescribing) of 31% as
opposed to an actual treatment rate of 42% when clini-
cians could override the CPR recommendations (con-
trol group treatment rate 42.1 and 41.7% in the entire
study cohort). In a secondary analysis of another
included study, clinicians requested objective testing
for 19 of 66 patients classified as low risk (and eligible
for early discharge) by the care pathway including the
CPR (none of the 19 patients had a MACE during
follow-up). Had the recommendation of the care path-
way been followed, the rate of early discharge wouldhave increased from 40 to 53% [47]. Such information
is likely to assist in the interpretation of impact study
findings by informing of the interactions taking place
between the clinician and the CPR and the reasons for
any disagreements.
Though clear reporting of interventions is necessary
for interpretation of study findings and safe replication
of the intervention in practice [52], documentation of
the interventions tested in the majority of the included
studies was poor. This is similar to research on other
complex interventions and non-pharmaceutical treat-
ments [53, 54]. Furthermore, studies rarely stated how a
diagnostic CPR is expected to alter outcomes relative to
the alternate diagnostic strategy, making it difficult to
judge the adequacy of the outcomes reported. For many
of the included studies where the control intervention
could broadly be described as usual care, no or minimal
description of the test method or the criteria by which
management decisions were made was provided. Usual
care had various permutations ranging from what is
termed ‘wild type’ or ‘care as it is now’, to a more regi-
mented guideline-driven care [55, 56]. It is acknowl-
edged that such strategies are internalised, likely
complex, probably highly variable and nuanced and diffi-
cult to translate into a prescriptive format. However, lack
of even mention of the tests performed makes it very
difficult to interpret differences in trial outcomes and to
judge generalisability. Furthermore, basic details about
the process of implementation were infrequently re-
ported, making it difficult to know whether failure to
demonstrate an effect is more likely due to inadequate
implementation of the experimental strategy, than lack
of effect of the experimental intervention itself. Nor did
the majority of studies provide information on which to
judge the risk of behaviour change among clinicians in
the control groups arising from knowledge of study con-
ditions [56].
Despite the importance of patient-centred outcomes
for informing decision-making, few studies included in
this review report any patient outcomes, and fewer still
report patient outcomes as the primary study outcome.
Clinicians’ decisions to test or treat are the primary out-
comes, and sometimes the only study outcome, in the
majority of the included studies. There may be several
explanations for this: randomised studies reporting pa-
tient outcomes are difficult, costly and time consuming
to conduct; researchers may believe that patient manage-
ment is a valid surrogate for health outcomes; or re-
searchers may select outcomes that reflect the primary
intention of many diagnostic CPRs to reduce testing or
treatment. However, recent research suggests that it is
not possible to infer the effects of a diagnostic test on
patient outcomes based on how a test influences man-
agement decisions. In an analysis of a large sample of
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index test on further diagnostic and therapeutic inter-
ventions did not correlate with the effects on patient
outcomes [2]. This study also found that estimates of ac-
curacy do not inform well about the clinical utility of
diagnostic tests. Given the multitude of ways CPRs may
affect patient outcomes [3, 4], improved accuracy or
management decisions afforded by a CPR are neither a
necessary requisite nor a guarantee for improving pa-
tient health. Though measurement of the effects of CPRs
on patient management may be of some use for plan-
ning further evaluations of a CPR, and as part of a suite
of outcome measures to assist in understanding the
means by which a CPR may exert its effects, we argue
that impact studies reporting only management deci-
sions, or reporting management decisions without con-
sidering effects on patient outcomes, are insufficient to
judge the clinical utility of diagnostic CPRs.
To our knowledge, this is the first review specifically
of diagnostic CPRs across a range of clinical conditions.
We are aware of one recently published systematic re-
view evaluating the impact of diagnostic and prognostic
CPRs (as a stand-alone tool) for conditions encountered
in primary care [11]. Similarly, this review identified only
a small number of studies evaluating the impact of CPRs
in a limited number of clinical domains. Lack of evi-
dence about the effect of use of diagnostic CPRs may be
one factor contributing to their limited uptake into prac-
tice. Conventionally, CPRs are required to go through
the stages of derivation, validation and impact analysis
prior to full implementation in practice. This rigorous
requirement is seemingly inconsistent with the situation
for other diagnostic tests (such as point of care tests),
which are frequently and fervently adopted into practice
on the basis of demonstrated practical advantage or ac-
curacy against a reference standard alone. Our review
was limited to studies randomly allocating participants
to care with or without a diagnostic CPR. However, it is
likely, as examination of our table of excluded studies
and the review of Wallace [11] suggests, that the use of
non-randomised and uncontrolled study designs to as-
sess the impact of diagnostic CPRs is reasonably com-
mon. This may reflect the practical and methodological
challenges in performing randomised trials in the clinical
setting particularly for conditions with potentially ser-
ious and often infrequent outcomes. While examining
evaluations using non-randomised and observational de-
signs would have contributed to the overall evidence
base, only randomised controlled trials can rule out the
possibility that an observed association between an
intervention and outcome is caused by a third factor
linked to both. The findings of our review, that CPRs re-
duce prescribing and test ordering for some conditions,
are also generally consistent with existing researchevaluating clinical decision support tools more broadly,
which has found that some systems can improve test or-
dering and antibiotic prescribing behaviour [6–8].
Our review has limitations. Because of the large num-
ber of titles and abstracts retrieved in the searches, only
one reviewer performed screening of titles and abstracts,
with a second reviewer screening only a proportion.
Therefore, some studies may have been overlooked.
However, screening of systematic reviews of clinical de-
cision support systems, reference checks and forward
searches minimised the possibility that eligible studies
were missed. The presence of study publication bias in
this review is possible. For instance, many of the CPRs
were tested by the researchers who developed the CPR
and thus may be more likely to submit studies with posi-
tive results for publication. In reporting whether a study
described components of the interventions, we deter-
mined only whether a description was present, rather
than providing a judgment about the adequacy of the
description. Consequently, the review is likely to over-
estimate the reporting quality of the included studies, as
components were judged to have been described even if
only partially so or with little detail. Furthermore, the
criteria assessed were considered by the authors to be
the minimum essential to the reporting of intervention
content. To properly appraise reporting quality of im-
pact studies, more criteria should be considered.
Conclusions
This review provides insight into the current status of
research evaluating the impact of diagnostic CPRs and
provides information that may assist clinicians and pol-
icymakers’ decisions regarding the application of these
tools. This review found that diagnostic CPRs improve
process of care measures for some clinical conditions
and in some cases improved or maintained patient
health while providing other benefits. However, this con-
clusion is based on a small number of studies, many of
which are judged to be at high or unclear risk of bias
and is likely to be context dependent. It is apparent from
this review that future impact studies need to be more
carefully designed and conducted and more thoroughly
reported. Consideration of the many mechanisms by
which a CPR may alter outcomes during the trial design
stage should guide the nature and number of outcomes
measured and facilitate understanding of why particular
effects are observed. Use of a framework such as that de-
veloped by Ferrante di Ruffano and colleagues [3] may
assist firstly in identifying the means by which a CPR
may alter the existing diagnostic pathway and secondly
to consideration of the full range of direct and down-
stream outcomes that should be measured. Furthermore,
reporting of such studies should be improved to assist
interpretation and replication in practice. Establishing
Sanders et al. Diagnostic and Prognostic Research  (2017) 1:13 Page 16 of 17benefit to patient health or showing that patient health
can be maintained while providing other benefits should
be the priority of impact evaluations of diagnostic pre-
diction rules.
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